Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE BOURRUST ET CIE : revenue, balance sheet and financial ratios

SELARL PHARMACIE BOURRUST ET CIE is a French company founded 34 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CASTELNAUDARY (11400), this company of category PME shows in 2025 a net income positive of 294 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE BOURRUST ET CIE (SIREN 388088080)
Indicator 2025 2024 2023 2022 2021 2020 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 294 417 € 297 944 € 279 265 € 407 180 € 478 375 € 0 € 249 287 € 107 367 € 74 739 € 156 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE BOURRUST ET CIE generates positive net income of 294 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 156 € -> 294 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

294 417 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 25%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

25.36%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

57.09%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.0%

Solvency indicators evolution
SELARL PHARMACIE BOURRUST ET CIE

Sector positioning

Debt ratio
25.36 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good +7 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE BOURRUST... (25.36) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
57.09% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good -13 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE BOURRUST... (57.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 207.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

207.755

Liquidity indicators evolution
SELARL PHARMACIE BOURRUST ET CIE

Sector positioning

Liquidity ratio
207.75 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good

In 2025, the liquidity ratio of SELARL PHARMACIE BOURRUST... (207.75) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE BOURRUST ET CIE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE BOURRUST ET CIE is estimated at 4 676 849 € (range 3 173 731€ - 7 338 620€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
3173k€ 4676k€ 7338k€
4 676 849 € Range: 3 173 731€ - 7 338 620€
NAF 5 année 2025

Valuation method used

Net Income Multiple
294 417 € × 15.9x = 4 676 849 €
Range: 3 173 732€ - 7 338 620€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE BOURRUST ET CIE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE BOURRUST ET CIE

What is the revenue of SELARL PHARMACIE BOURRUST ET CIE ?

The revenue of SELARL PHARMACIE BOURRUST ET CIE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE BOURRUST ET CIE profitable?

Yes, SELARL PHARMACIE BOURRUST ET CIE generated a net profit of 294 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE BOURRUST ET CIE ?

The headquarters of SELARL PHARMACIE BOURRUST ET CIE is located in CASTELNAUDARY (11400), in the department Aude.

Where to find the tax return of SELARL PHARMACIE BOURRUST ET CIE ?

The tax return of SELARL PHARMACIE BOURRUST ET CIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE BOURRUST ET CIE operate?

SELARL PHARMACIE BOURRUST ET CIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.